Bajaj Healthcare liquidity ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
3.51×————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
1.78×1.78×1.78×1.08×1.17×
1.10×1.10×1.19×0.70×0.69×
13.537.22.62.217.7
24825021330.073.7
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

BAJAJHCARE₹312.85

Bajaj Healthcare Limited

· Pharma & Health
₹ CrorePeersTHEMISMEDLINCOLNWANBURYSIGACHIAHCLANUHPHRAMRUTANJANMcap ₹1,053 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Altman Z-Score (Other Equity as RE)————3.51
Current Ratio1.171.081.781.781.78
Quick Ratio0.690.701.191.101.10
Cash, Equiv & ST Investments17.72.22.637.213.5
Working Capital73.730.0213.1249.5247.9
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.